|
|
Other links at Articles > Pharmacists |
| 2. |
U.S. Panel Sees Anemia Drug Risks in Kidney Patients
|
|
|
Use of controversial anemia drugs made by Amgen Inc and Johnson & Johnson at high levels likely worsen heart problems and possibly chances for survival in kidney patients, a U.S. Medicare advisory panel said on Wednesday, calling for more study. Reuters Health Information
|
|
|